OrbusNeich Medical Group Holdings Limited (HKG:6929)

Hong Kong · Delayed Price · Currency is HKD

3.920

-0.020 (-0.51%)

Jun 18, 2026, 3:59 PM HKT

10.42% (1Y)

Market Cap	3.23B +4.3%
Revenue (ttm)	1.40B +10.0%
Net Income	326.12M +5.5%
EPS	0.40 +5.6%
Shares Out	823.25M
PE Ratio	9.91
Forward PE	9.28
Dividend	0.12 (3.08%)
Ex-Dividend Date	Jun 10, 2026

Volume	55,000
Open	3.930
Previous Close	3.940
Day's Range	3.910 - 4.060
52-Week Range	3.450 - 5.710
Beta	-0.65
Analysts	Strong Buy
Price Target	5.66 (+44.39%)
Earnings Date	Aug 14, 2026

About HKG:6929

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, drug-coated balloons and stents for lesion therapy, non-compliant balloons for post-dilatation, and specialty catheters, as well as microcatheters, guide catheter extension, dual therapy, and drug eluting stents. Its ... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2001

Employees 1,477

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 6929

Full Company Profile

Financial Performance

In 2025, HKG:6929's revenue was $180.45 million, an increase of 9.97% compared to the previous year's $164.10 million. Earnings were $41.90 million, an increase of 5.49%.

Financial numbers in USD Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 6929 stock is "Strong Buy." The 12-month stock price target is $5.66, which is an increase of 44.39% from the latest price.

Price Target

$5.66

(44.39% upside)

Analyst Consensus: Strong Buy

Stock Forecasts